William R. Fair
#123,513
Most Influential Person Now
William R. Fair's AcademicInfluence.com Rankings
William R. Fairphilosophy Degrees
Philosophy
#5676
World Rank
#8548
Historical Rank
Logic
#2916
World Rank
#3989
Historical Rank
William R. Fairbiology Degrees
Biology
#7637
World Rank
#10587
Historical Rank
Molecular Biology
#898
World Rank
#921
Historical Rank
Biochemistry
#1057
World Rank
#1172
Historical Rank
Download Badge
Philosophy Biology
William R. Fair's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is William R. Fair Influential?
(Suggest an Edit or Addition)William R. Fair's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prostate-specific membrane antigen expression in normal and malignant human tissues. (1997) (1334)
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse (1989) (677)
- Report of the United States cooperative study of extracorporeal shock wave lithotripsy. (1986) (650)
- DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER (1998) (616)
- Expression of the prostate-specific membrane antigen. (1994) (573)
- Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. (1993) (536)
- Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. (1993) (524)
- The treated natural history of high risk superficial bladder cancer: 15-year outcome. (1997) (514)
- The TNM classification of prostate cancer (1992) (461)
- The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. (1991) (448)
- Intensive lifestyle changes may affect the progression of prostate cancer. (2005) (438)
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (1999) (379)
- Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. (1992) (345)
- Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? (1978) (330)
- Incidence and clinical significance of false-negative sextant prostate biopsies. (1998) (324)
- Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. (1993) (312)
- Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. (1995) (284)
- Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. (1995) (263)
- Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. (1994) (255)
- Genetic alterations in bladder cancer (1993) (252)
- Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. (1989) (248)
- Molecular genetic alterations in superficial and locally advanced human bladder cancer. (1991) (248)
- Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. (1997) (241)
- Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. (1991) (229)
- Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. (1989) (226)
- Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma (1993) (208)
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. (1987) (208)
- Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. (1994) (206)
- The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma (1987) (203)
- Adult urological sarcoma. (1992) (198)
- Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. (1995) (196)
- Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. (1999) (195)
- Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. (1994) (189)
- Typing of prostate tissue by ultrasonic spectrum analysis (1996) (188)
- Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup. (1992) (182)
- Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. (1989) (175)
- Regression of bladder tumors in mice treated with interleukin 2 gene- modified tumor cells [published erratum appears in J Exp Med 1993 Jun 1;177(6):following 1831] (1993) (172)
- Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. (1997) (171)
- Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. (1998) (168)
- Prostatic antibacterial factor. Identity and significance. (1976) (159)
- Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. (1996) (147)
- Clinical stage I testis cancer: long-term outcome of patients on surveillance. (1998) (147)
- High energy shock waves suppress tumor growth in vitro and in vivo. (1986) (141)
- Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma (1994) (139)
- Flow cytometry of prostate cancer: relationship of DNA content to survival. (1987) (139)
- Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. (1998) (137)
- Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. (1974) (136)
- Cancer of the prostate: a nutritional disease? (1997) (136)
- Development and progression of clubbing and scarring in children with recurrent urinary tract infections. (1974) (135)
- Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. (1996) (134)
- Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. (1996) (133)
- Salvage chemotherapy for patients with germ cell tumors. The memorial sloan‐kettering cancer center experience (1979–1989) (1991) (131)
- Radical cystectomy in the octogenarian. (1997) (127)
- Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. (1987) (123)
- Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. (2002) (121)
- Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer. (1992) (116)
- Clinical significance of repeat sextant biopsies in prostate cancer patients. (1997) (113)
- Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. (1992) (111)
- Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues. (1986) (110)
- Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. (1999) (108)
- Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. (1994) (107)
- Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. (1992) (106)
- Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. (1994) (106)
- The impact of primary stage on survival in patients with lymph node positive bladder cancer. (1999) (105)
- The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors (1990) (104)
- Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. (2003) (104)
- Indications for transition zone biopsy in the detection of prostatic carcinoma. (1997) (103)
- Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. (1982) (102)
- High‐dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated (1992) (102)
- Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder Cancer (1993) (101)
- Free radical production by high energy shock waves--comparison with ionizing irradiation. (1988) (98)
- Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. (1987) (98)
- Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen. (1989) (96)
- Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. (1997) (96)
- The pH of prostatic fluid: a reappraisal and therapeutic implications. (1978) (96)
- Extracorporeal shock-wave lithotripsy for upper urinary tract calculi. One year's experience at a single center. (1986) (95)
- Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. (1994) (94)
- Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. (1994) (93)
- Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. (1990) (89)
- Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma. (1988) (88)
- Formalin in the treatment of massive bladder hemorrhage. Techniques, results, and complications. (1974) (87)
- Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinoma (1992) (85)
- Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. (1987) (83)
- Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves. (1987) (82)
- Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. (1995) (80)
- The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan‐kettering cancer center experience (1994) (80)
- The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. (1997) (80)
- Clinical and laboratory studies into the pathogenesis of malacoplakia. (1976) (76)
- Are excretory urograms necessary in evaluating women with urinary tract infection? (1979) (75)
- Allelic deletions in renal tumors: histopathological correlations. (1993) (74)
- Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis. (1996) (74)
- Prostate‐specific membrane antigen (1997) (74)
- The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. (1994) (73)
- Spectrum-Analysis and Neural Networks for Imaging to Detect and Treat Prostate Cancer (2001) (68)
- Advanced seminoma: the role of chemotherapy and adjunctive surgery. (1988) (68)
- Radical Cystectomy for Invasive Bladder Cancer: Contemporary Results and Remaining Controversies (2000) (68)
- Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. (1989) (65)
- Combating prostate cancer. (1998) (64)
- Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model (2000) (63)
- Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. (1994) (63)
- Ultrasonic spectral-parameter imaging of the prostate (1997) (62)
- Prostate Cancer: Emerging Concepts: Part I (1996) (61)
- Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. (1997) (61)
- Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. (2000) (60)
- Surgical treatment of brain metastases from renal cell carcinoma. (1990) (58)
- The management of clinically unconfirmed positive urinary cytology. (1993) (57)
- Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration. (1979) (56)
- Erratum: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells (Journal of Experimental Medicine (April 1993) 177 (1127)) (1993) (56)
- Dietary trial in prostate cancer: Early experience and implications for clinical trial design. (2001) (55)
- Heparin‐binding growth factor isolated from human prostatic extracts (1988) (53)
- Regression of metastatic renal cell carcinoma: a case report and literature review. (1986) (53)
- The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. (1990) (53)
- A re-appraisal of treatment in chronic bacterial prostatitis. (1979) (52)
- Ureteral carcinoma in situ at radical cystectomy: does the margin matter? (1997) (52)
- Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. (1988) (52)
- Selective binding of zinc ions to heparin rather than to other glycosaminoglycans. (1981) (50)
- Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha. (2000) (49)
- Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma. (1989) (48)
- Intraoperative sonography: application in renal cell carcinoma. (1988) (47)
- Bacteriologic and hormonal observations of the urethra and vaginal vestibule in normal, premenopausal women. (1970) (47)
- Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor. (1984) (47)
- Urinary polyamine levels in the diagnosis of carcinoma of the prostate. (1975) (47)
- Is the flare phenomenon clinically significant? Commentary (2001) (46)
- Clinical applications of a kinetic model of hippurate distribution and renal clearance. (1974) (46)
- Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer. (1996) (46)
- Three-day treatment of urinary tract infections. (1980) (46)
- Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery. (1990) (45)
- Cytotoxicity of high energy shock waves: methodologic considerations. (1989) (45)
- Management of children with urinary tract infections: the Stanford experience. (1975) (45)
- Treatment of a metastatic prostate derived tumor with surgery and chemotherapy. (1982) (45)
- Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. (1999) (44)
- Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation. (1995) (43)
- DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. (1991) (42)
- The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. (1988) (41)
- A correlation of seminal polyamine levels and semen analysis in the human. (1972) (40)
- Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma. (1987) (40)
- Three-dimensional ultrasound analyses of the prostate. (2000) (40)
- Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma (1994) (40)
- Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry (1986) (40)
- Willet F. Whitore, Jr. Lecture: back to the future--the role of complementary medicine in urology. (1999) (40)
- Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer. (2002) (40)
- Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer (1996) (39)
- Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. (1998) (39)
- Endoscopic bladder neck suspension for stress urinary incontinence. (1984) (39)
- Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. (1996) (38)
- Analysis of p21WAF1/CIP1 in primary bladder tumors. (1998) (38)
- Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer. (1993) (38)
- Prostate Cancer: Emerging Concepts (1996) (36)
- Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal models. (1977) (36)
- Abbott IMx evaluated for assay of prostate-specific antigen in serum. (1992) (36)
- Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma. (1989) (36)
- Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study. (1997) (35)
- Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. (1992) (35)
- Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of technique. (1998) (35)
- Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer. (1998) (35)
- Percutaneous nephrostomy: indications, complications and clinical usefulness. (1978) (34)
- Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors. (1992) (33)
- Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer. (2000) (33)
- Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma. (1976) (32)
- Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin. (1989) (32)
- Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney. (1988) (31)
- The selective in vivo incorporation and metabolism of radioactive putrescine in the adult male rat. (1975) (31)
- Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study. (1982) (30)
- Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence. (1994) (30)
- Suppression of in vitro and in vivo tumor growth by high- energy shock waves (1985) (30)
- Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors (1990) (29)
- Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer. (1994) (28)
- Diffusion of minocycline into prostatic secretion in dogs. (1974) (28)
- A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma. (1992) (28)
- TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. (1995) (27)
- Computed tomography of the genitourinary tract. (1978) (27)
- The purification and assay of the prostatic antibacterial factor (PAF). (1973) (27)
- Mitogenic factors in prostatic tissue and expressed prostatic secretion. (1985) (26)
- Progress in prostate cancer chemoprevention: modulators of promotion and progression. (2001) (26)
- [Incidence and clinical significance of false-negative sextant biopsies of the prostate]. (1998) (25)
- Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? (2002) (25)
- Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. (1987) (25)
- Anti-androgenic effects of combination finasteride plus flutamide in patients with prostatic carcinoma. (1996) (25)
- An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer (1994) (25)
- Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer. (2002) (25)
- Priapism of the Proximal Penis (1980) (25)
- Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate. (1984) (25)
- Prognostic significance of antigenic heterogeneity, gleason grade, and ploidy of lymph node metastases in patients with prostate cancer (1992) (25)
- Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors. (1994) (24)
- Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy. (1997) (24)
- Prostate-specific membrane antigen and other prostatic tumor markers on the horizon. (1997) (23)
- The pH of prostatic fluid: a reappraisal and therapeutic implications. (1978) (23)
- Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane. (1982) (22)
- A Curve Analyzer and General Purpose Graphical Computer (1954) (22)
- Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. (1997) (22)
- The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer. (1994) (22)
- The Corporate CIA---A Prediction of Things to Come (1966) (22)
- Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice. (1995) (21)
- Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. (1994) (21)
- Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL. (1999) (21)
- Ischiopagus tetrapus twins: urological aspects of separation and 10-year followup. (1991) (21)
- Impact of shockwave lithotripsy on upper urinary tract calculi. (1986) (21)
- Partial cystectomy during radical surgery for nonurological malignancy. (2001) (20)
- The treatment of infection stones with penicillin. (1979) (20)
- Difluoromethylornithine enhancement of putrescine uptake into the prostate: concise communication. (1982) (19)
- Metallothionein gene expression in bladder cancer exposed to cisplatin. (1993) (19)
- Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia. (1983) (19)
- Testicular failure in patients with extragonadal germ cell tumors (1987) (18)
- Antibacterial action of spermine: effect on urinary tract pathogens. (1971) (18)
- Expression of blood group antigens in bladder cancer: current concepts. (1992) (18)
- Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology. (1987) (18)
- M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation. (1990) (17)
- Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretions (2004) (17)
- Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). (1988) (17)
- Differential renal function studies in segmental renal ischemia. (1971) (16)
- Antibacterial substances in prostatic fluid. (1981) (16)
- Interstitial Irradiation in Prostatic Cancer: Report of 10-Year Results (1987) (16)
- Renal perfusion/excretion determination renogram: a new tool in the diagnostic evaluation of renovascular hypertension. (1975) (16)
- The effect of High energy shock waves (HESW) on human bone marrow (2004) (16)
- The pharmacokinetics of antibiotic diffusion in chronic bacterial prostatitis (1982) (16)
- Urinary tract infections in children. Part I-- Young girls with non-refluxing ureters. (1974) (16)
- Simultaneous detection of fluorescent in situ hybridization and in vivo incorporated brdu in a human bladder tumour (1991) (16)
- CT scanning in urology. (1979) (15)
- Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysis. (1988) (15)
- Initial evaluation of a new epithelial antigen (T16) for bivariate flow cytometry of bladder irrigation specimens. (1989) (15)
- Further Observations on the Antibacterial Nature of Prostatic Fluid (1971) (14)
- The in vitro effect of high energy shock waves on human prostate cancer cell line PC-3 (1985) (14)
- Renal cell carcinoma and the clonogenic assay. (1983) (14)
- Principles and Management of Testicular CancerN. Javadpour, Georg Thieme Verlag, New York (1986), p. 413 pages (1987) (14)
- Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen. (1988) (14)
- Urinary tract infections in children. Part III--Treatment of ureterovesical reflux. (1974) (14)
- Prostate specific antigen doubling time after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy. (1999) (13)
- Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection. (1986) (13)
- Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer. (2000) (13)
- Renal back pressure atrophy with compromised renal function due to diabetes insipidus. Case report. (1971) (12)
- Perioperative use of carbenicillin in transurethral resection of prostate. (1986) (12)
- Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience. (1997) (12)
- Growth inhibition of a prostate tumor by α-difluoromethylornithine and by cyclophosphamide☆ (1982) (12)
- Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells. (1995) (12)
- First International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: overview consensus statement. (1997) (12)
- Clinical value of sensitivity determinations in treating urinary tract infections. (1982) (12)
- Overview consensus statement. (2001) (12)
- Influence of vesico-ureteral reflux on the response to treatment of urinary tract infections in female children. (1976) (12)
- Clinical value of sensitivity determinations in treating urinary tract infections. (1982) (12)
- Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience. (1990) (11)
- Imaging of canine tumors with 11C-methylputrescine. (1978) (11)
- Two-dimensional and three-dimensional tissue-type imaging of the prostate based on ultrasonic spectrum analysis and neural network classification (2000) (11)
- INTESTINAL OBSTRUCTION IN THE NEWBORN: AN UNUSUAL CASE DUE TO MESENTERIC CYST. (1965) (11)
- Editorial: Prostate Cancer--Nutrition Adjunct Therapy (1996) (11)
- Detection of bladder carcinoma in females by flow cytometry and cytology. (1989) (11)
- Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology. (1987) (10)
- Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor. (1981) (10)
- Ultrasonic tissue typing of prostate tissue (1994) (10)
- Xanthogranulomatous pyelonephritis masquerading as occult malignancy. (1978) (10)
- Is combined modality therapy appropriate for apparently localized carcinoma of the prostate? (1991) (10)
- Advanced ultrasonic tissue-typing and imaging based on radio-frequency spectrum analysis and neural-network classification for guidance of therapy and biopsy procedures (2001) (10)
- Association of type 1 blood group antigens with urinary tract infections in children with genitourinary structural abnormalities. (1990) (10)
- Radionuclide imaging of dog prostate. (1978) (10)
- Treatment of advanced prostatic cancer. (1987) (9)
- Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor. (1981) (9)
- Interstitial irradiation using I-125 seeds. (1987) (9)
- Cytotoxic activity of aziridinyl putrescine enhanced by polyamine depletion with alpha-difluoromethylornithine. (1985) (9)
- Ureteropyeloscopy: the diagnostic and therapeutic approach to upper tract urothelial tumors (1985) (9)
- Three-dimensional ultrasonic parametric and tissue-property imaging for tissue evaluation, treatment planning, therapy guidance, and efficacy assessment (2000) (8)
- The natural history of locally confined prostate cancer: A review (1992) (8)
- Prophylactic antibiotics in urologic surgery. (1983) (8)
- Vasectomy and vasovasostomy have no effect on seminal plasma zinc concentrations. (1987) (8)
- 3-D tissue typing of prostate tissue based on spectral parameters (1995) (8)
- DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage. (1990) (8)
- The prostatic antibacterial factor: identity and significance. (1976) (8)
- Blood group antigen expression in bladder tumors: An immunohistochemical study of superficial bladder lesions (1994) (8)
- Translational Research Trends: Urologic Gene Therapy (2000) (7)
- Bladder cancer: advances in biology and treatment. (1994) (7)
- Cell surface differentiation antigens of normal urothelium and bladder tumors. (1992) (7)
- 2-D images for biopsy guidance and 3-D images for treatment planning and monitoring of prostate cancer based upon spectrum analysis and neural-network classification (1999) (7)
- Late ureteric obstruction following ureteral reimplantation for reflux: a warning. (1974) (7)
- Effect of surgery and adjuvant chemotherapy on the R3327 MAT‐Ly Lu tumor (1981) (7)
- Perspectives on prostate cancer diagnosis and treatment: a roundtable. (2001) (7)
- Comparison of split function ratios with renal vein renin ratios in patients with curable hypertension caused by unilateral renal artery stenosis. (1974) (7)
- Advanced ultrasonic imaging of the prostate for guiding biopsies and for planning and monitoring therapy (2000) (7)
- Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT). (1988) (7)
- The location of antibacterial activity in the rat prostatic secretions. (1973) (7)
- Identification of a new receptor subtype for tumor necrosis factor-alpha. (1993) (7)
- Hormonal therapy of advanced prostatic cancer. (1986) (6)
- Internal urethrotomy without a catheter: use of a urethral stent. (1982) (6)
- Difficulties in the evaluation of hypertension secondary to renal ischemia. (1970) (6)
- Neoadjuvant therapy prior to radical prostatectomy: pro. (1996) (6)
- The effect of cephaloridine on normal renal function. (1972) (6)
- Historical perspective on prostate brachytherapy. (2000) (6)
- The antibacterial action of canine prostatic fluid and human seminal plasma in an agar diffusion assay system. (1973) (6)
- Posterior urethral valves. (1977) (6)
- Urinary tract infections in children. Part II--Roentgenologic aspects. (1974) (6)
- Improved prostate biopsy guidance using ultrasonic tissue-typing images (1996) (6)
- Clinical Downstaging After Neo-Adjuvant M-VAC for Transitional Cell Carcinoma of the Urothelium (1987) (6)
- 2- and 3-D differentiation of cancerous from benign prostate tissue for diagnosis, monitoring, and planning based on spectrum analysis (1997) (5)
- Flow cytometric analysis of primary adenocarcinoma of the bladder. (1987) (5)
- Neoadjuvant therapy in invasive bladder cancer. Problems and pitfalls. (1991) (5)
- M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium. (1988) (5)
- Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities. (1985) (5)
- Carcinoma of the prostate: Diagnosis and staging (1983) (5)
- Screening for carcinoma of the prostate: Efficacy of available screening tests (2005) (5)
- Carcinoma of the prostate: current thoughts on diagnosis and staging. (1982) (5)
- Analogue Computations of Business Decisions (1953) (4)
- The role of dietary manipulation in biochemical recurrence of prostate cancer after radical prostatectomy. (1999) (4)
- The relationship of bacterial prostatitis and zinc. (1977) (4)
- Molecular and cytogenetic events in urologic tumors. (1988) (3)
- Renovascular hypertension: the role of the urologist. (1975) (3)
- Pripism of the proximal penis. (1980) (3)
- Evaluation of chemotherapy in bladder cancer (1992) (3)
- Growth inhibition of a prostate tumor by alpha-difluoromethylornithine and by cyclophosphamide. (1982) (3)
- Prostatic tumor implantation in the nude mouse via a perineal approach (1997) (3)
- Predicting the metastatic potential of prostatic cancer: Is lymph node staging necessary? (1987) (3)
- Why not neo-adjuvant therapy for prostatic carcinoma? (1991) (3)
- Specific membrane antigen prostatic hyperplasia. (1993) (3)
- Prostate-Specific Membrane Antigen in the Diagnosis of Prostatic Carcinoma (1995) (2)
- Ultrasonic, Spectrum-Analysis, Tissue-Typing Images for Prostate-Biopsy Guidance and Staging (1997) (2)
- Antibacterial Action of Spermine: Effect on Urinary Tract Pathogens (1971) (2)
- Prostate cancer--nutrition adjunct therapy. (1996) (2)
- Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. (2000) (2)
- Technique for the management of Santorini's deep venous plexus during radical retropubic prostatectomy (1994) (2)
- Technique for the management of Santorini's deep venous plexus during radical retropubic prostatectomy (1994) (2)
- Renal abscess. (1970) (2)
- Immunopathology--new help for the clinician. (1988) (2)
- In Vitro Assays for Directing Therapy of Genitourinary Cancers (1984) (2)
- Hematuria 5 Months after Left Radical Nephrectomy (1983) (1)
- Biochemical markers for prostatic carcinoma. (1987) (1)
- A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors (1989) (1)
- Prostate-derived growth factors. (1984) (1)
- Superficial Bladder Cancer (1997) (1)
- Glass foreign object in the kidney. (1971) (1)
- Absence of structural alterations of the multidrug resistance genes in transitional cell carcinoma (2004) (1)
- Effects of intermittent estrogen administration on the R3327H rat prostatic carcinoma (1986) (1)
- Immunodiagnosis and immunoimaging. (1988) (1)
- Hypocellular bladder wash specimens and their clinical significance. (1993) (1)
- End-to-end transureteroureterostomy: a report of 2 cases. (1981) (1)
- Prostate-specific membrane antigen and other prostatic tumor markers on the horizon : Prostate-specific antigen: the best prostatic tumor marker (1997) (1)
- Loss of avidin-binding activity in renal cell carcinoma (1990) (1)
- Urinary tract infections--current status. (1983) (0)
- Farewell and Thank You (2001) (0)
- RE: BACK TO FUTURE-THE ROLE OF COMPLEMENTARY MEDICINE IN UROLOGY (1999) (0)
- Three‐dimensional prostate imaging and tissue typing (1996) (0)
- REVERSAL OF RADIATION RESISTANCE IN LNCaP VIA CERAMIDE SYNTHASE ACTIVATION (1999) (0)
- Effects of Intermittent Diet hvIstà 1⁄4 bestrol Diphosphate Administration on the R 3327 Rat Prostatic Carcinoma (2006) (0)
- Mitogenic activity of prostatic extracts. (1987) (0)
- Cellular analysis of tumor markers in genitourinary tumors (1997) (0)
- Memorandum from William R. Fair to Joshua Lederberg (1973) (0)
- Bacterial Prostatitis and Benign Prostatic Hypertrophy (1983) (0)
- Specificity analysis of two new mouse monoclonal antibodies reactive with prostate cancer (1987) (0)
- Prostate-specific Membrane Antigen Molecular Cloning of a Complementary DNA Encoding a Updated (2007) (0)
- ADVANCED 2-D AND 3-D ULTRASONIC IMAGING IN DIAGNOSIS OF PROSTATE CANCER (1999) (0)
- INFLUENCE OF SMOKING STATUS ON OUTCOMES IN PATIENTS WITH TOBACCO-ASSOCIATED SUPERFICIAL TRANSITIONAL CELL CARCINOMA (TCC) OF THE BLADDER (1999) (0)
- Clinicopathological conference. Hematuria 5 months after left radical nephrectomy. (1983) (0)
- Non-Surgical Management of Vesicourethral Dysfunction (1984) (0)
- NUTRITION & PROSTATE CANCER A Monograph from the CaP CURE Nutrition Project NUTRITION & PROSTATE CANCER A Monograph from the CaP CURE Nutrition Project The Association for the Cure of Cancer of the Prostate (1998) (0)
- Kinetics of androgen repressed gene expression following endocrine ablation and coumarin exposure (1990) (0)
- Prostate cancer. (1997) (0)
- The polyamine synthesis inhibitor alpha-difluoromethylornithine (DFMO) enhances putrescine uptake into the androgen stimulated castrated rat prostate (1981) (0)
- Primary carcinoma of the bulbo-membranous urethra. (1989) (0)
- FINASTERIDE PLUS FLUTAMIDE FOR PROSTATIC CARCINOMA. AUTHORS' REPLY (1997) (0)
- Cytokine Gene Modification of Bladder Cancer Cells for the Establishment of Bladder Cancer Vaccine (1996) (0)
- PROSTATE CANCER : EMERGING CONCEPTS. AUTHORS' REPLY (1996) (0)
- Prostate specific antigen membranes and its applications (1996) (0)
- Effect of chemotherapeutic agents on the putrescine transport into R3327MAT-Lu prostate derived tumor cells in vitro (1982) (0)
- Reduced glutathione is not required for measurement of alpha-D-glucosidase in human seminal plasma. (1981) (0)
- In situ gene transfection of bladder cancer cells with retrovirus and herpes simplex virus vector for the treatment of bladder cancer (1997) (0)
- Introduction--translational research trends: urologic gene therapy. (2000) (0)
- Clinical and laboratory studies into the pathogenesis of malacoplakia Report of Cases CASE (0)
- Organ conservation in deeply invasive bladder cancer. (1991) (0)
- Organ conservation in deeply invasive bladder tumors: a valid approach? (1992) (0)
- Modulation of blood group antigens in human urothelial carcinoma (1988) (0)
- NUO 2902 Spectrum analysis for classifying and evaluating prostate tissue (1997) (0)
- Molecular weight determination of a growth factor present in human expressed prostatic secretions (1983) (0)
- Preliminary tissue-characterization studies of rat prostate in vivo☆ (1989) (0)
- [Basic research in uro-oncology--molecular biology emphasis and gene transfer techniques]. (1996) (0)
- Festschrift Urology Conference in Honor of Dr. Thomas A. Stamey. September 29-30, 2000. Stanford, California, USA. (2002) (0)
- Neoadjuvant chemotherapy for invasive bladder carcinoma. (1988) (0)
- Contents, Vol. 25, 1970 (1970) (0)
- Inhibition of clonogenicity of PC-3 prostatic cells by monoaziridinyl putrescine with and without pretreatment by the polyamine synthesis inhibitor, difluoromethyl-ornithine (1985) (0)
- Extracorporeal treatment of kidney stone using the shock wave lithotripser. (1986) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William R. Fair?
William R. Fair is affiliated with the following schools:
